This webinar, part of FTA's Tribal Transit Program, will focus on the funding, application eligibility and criteria, and the submission process.
Past Events
Webinar: Public Transportation Agency Safety Planning Frequently Asked Questions
This webinar, part of FTA's Public Transportation Agency Safety Planning (PTASP) webinar series, will focus on frequently asked questions pertaining to PTASP.
Webinar: Safety Management Policy and Safety Promotion (PTASP)
This webinar, part of FTA's Public Transportation Agency Safety Planning webinar series, will focus on Safety Management Policy and Safety Promotion.
Webinar: Bus and Bus Facilities FY19 Funding Opportunity
This webinar on May 15, 2019 will provide more information about FTA's ...
Webinar: Integrated Mobility Innovation Program Funding Opportunity
FTA's IMI 2019 funding opportunity provides $15 million for demonstration projects focused on three areas of interest: mobility on demand, transit...
Ridership Forecasting with STOPS for Transit Project Planning (May 2019)
The National Transit Institute (NTI) is sponsoring this course on transit ridership forecasting using FTA’s Simplified Trips-on-Project Software package (STOPS). FTA developed the course to provide training on STOPS...
14th Annual FTA Drug and Alcohol Program National Conference
This free three-day conference will provide attendees with background on Procedures for Transportation Workplace Drug and Alcohol Testing Programs (49 CFR Part 40) and Prevention of Alcohol Misuse and Prohibited Drug Use in Transit Operators (49 CFR Part 655).
Public Transportation Agency Safety Plan Final Rule Frequently Asked Questions
The Federal Transit Administration (FTA) will discuss the Public Transportation Agency Safety Plan (PTASP) final rule (49 C.F.R. Part 673). This 1-hour webinar beginning at 2:00 PM ET will be a questions and answers sessions about topics related to the PTASP Final Rule.
Webinar: Increase in Random Drug Testing Rates
This webinar to be held 2 p.m. ET Thursday, December 18, will cover the upcoming increase in random drug testing rates...